propranolol has been researched along with Epistaxis in 5 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Epistaxis: Bleeding from the nose.
Excerpt | Relevance | Reference |
---|---|---|
"The study demonstrated that combined therapy (sclerotherapy and topical nasal propranolol) significantly reduced the epistaxis due to HHT and increased patients' quality of life." | 7.91 | Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT-Epistaxis. ( Botella Cubells, L; Esteban-Casado, S; Marcos Salazar, MS; Martín de Rosales Cabrera, AM; Martínez Simón, JJ; Pérez Encinas, M; Usarralde Pérez, A; Zhan Zhou, E, 2019) |
"These preliminary results suggest that topical propranolol may be effective for the treatment of epistaxis in patients with HHT." | 7.85 | Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report. ( Blau, H; Bruckheimer, E; Goldschmidt, N; Mei-Zahav, M; Zur, E, 2017) |
" Administration (systemically or topically via a spray or gel) of timolol and propranolol showed mixed evidence of improvement in epistaxis frequency, severity, and duration when compared with control groups." | 5.22 | The Use of Beta-Blockers in Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review. ( Albarki, H; Rimmer, J, 2022) |
"The study demonstrated that combined therapy (sclerotherapy and topical nasal propranolol) significantly reduced the epistaxis due to HHT and increased patients' quality of life." | 3.91 | Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT-Epistaxis. ( Botella Cubells, L; Esteban-Casado, S; Marcos Salazar, MS; Martín de Rosales Cabrera, AM; Martínez Simón, JJ; Pérez Encinas, M; Usarralde Pérez, A; Zhan Zhou, E, 2019) |
"These preliminary results suggest that topical propranolol may be effective for the treatment of epistaxis in patients with HHT." | 3.85 | Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report. ( Blau, H; Bruckheimer, E; Goldschmidt, N; Mei-Zahav, M; Zur, E, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Albarki, H | 1 |
Rimmer, J | 1 |
Mei-Zahav, M | 1 |
Blau, H | 1 |
Bruckheimer, E | 1 |
Zur, E | 1 |
Goldschmidt, N | 1 |
Esteban-Casado, S | 1 |
Martín de Rosales Cabrera, AM | 1 |
Usarralde Pérez, A | 1 |
Martínez Simón, JJ | 1 |
Zhan Zhou, E | 1 |
Marcos Salazar, MS | 1 |
Pérez Encinas, M | 1 |
Botella Cubells, L | 1 |
Bjelakovic, B | 1 |
Bojanovic, M | 1 |
Lukic, S | 1 |
Saranac, L | 1 |
Vukomanovic, V | 1 |
Prijic, S | 1 |
Zivkovic, N | 1 |
Randjelovic, D | 1 |
Contis, A | 1 |
Gensous, N | 1 |
Viallard, JF | 1 |
Goizet, C | 1 |
Léauté-Labrèze, C | 1 |
Duffau, P | 1 |
1 review available for propranolol and Epistaxis
Article | Year |
---|---|
The Use of Beta-Blockers in Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Topics: Epistaxis; Humans; Propranolol; Prospective Studies; Quality of Life; Randomized Controlled Trials a | 2022 |
1 trial available for propranolol and Epistaxis
Article | Year |
---|---|
The therapeutic efficacy of propranolol in children with recurrent primary epistaxis.
Topics: Adrenergic beta-Antagonists; Child; Child, Preschool; Dose-Response Relationship, Drug; Epistaxis; F | 2013 |
3 other studies available for propranolol and Epistaxis
Article | Year |
---|---|
Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report.
Topics: Administration, Intranasal; Administration, Topical; Adult; Aged; Dose-Response Relationship, Drug; | 2017 |
Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT-Epistaxis.
Topics: Administration, Intranasal; Administration, Topical; Adult; Aged; Combined Modality Therapy; Cross-S | 2019 |
Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic telangiectasia: retrospective, then prospective study, in a total of 21 patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Epistaxis; Female; Humans; Male; Middle Aged; Propranolol; | 2017 |